Heritage Global Partners, in partnership with Copia Scientific, is selling late model R&D laboratory equipment from OncoMyx Therapeutics.
OncoMyx Therapeutics develops oncolytic immunotherapies for the treatment of cancer. The company was built on research that found the myxoma virus to be immuno-interactive, with the ability to selectively kill a number of cancer cell types.
The global online auction opens on the 15th of August and ends on the 16th of August. Equipment featured in the auction includes: Thermo ST Plus centrifuge; Bio Rad CFX Connect real time PCR; Sorvall Lynx 6000 superspeed centrifuge; BioTek Synergy HTX multi mode microplate reader; Echo RVL-100-M Revolve microscope; SPEX 1600 MiniG sample prep; (2) Epstpendorf Master Cycler Nexus GX2 PCR; Thermo NanoDrop Lite spectrophotometer; BioTek 50TS microplate washer; (3) Thermo 1300 Series 6′ biosafety cabinets; (3) Thermo 1300 Series 3′ biosafety cabinets; (2) Thermo TSX Series -80 freezers; VWR -80 freezer; (6) Thermo Steri Cycle CO2 incubators and more. The assets are located in Phoenix, Arizona and can be inspected by appointment with the auctioneer only.
Headquartered in San Diego, California Heritage Global Partners is a full-service auctioneering company managing sales at all scales – from single assets through to complete turnkey facilities and factories. The firm conducts 150-200 auctions each year and has collective experience in operating across 30 countries. Heritage Global Partners works with clients across more than 25 industries, including the electronics, pharmaceutical, energy and food and beverage sectors.
For further information about this, or any other Heritage Global Partners auction, please visit:
